Profile
International Journal of Clinical Research & Trials Volume 4 (2019), Article ID 4:IJCRT-139, 14 pages
https://doi.org/10.15344/2456-8007/2019/139
Review Article
Ocular Manifestations of Rheumatoid Arthritis: Implications of Recent Clinical Trials

Manjeet S. Bhamra1, Irfan Gondal2, Abhimanyu Amarnani2, Saul Betesh2, Angelina Zhyvotovska2, Wayne Scott3, Milena Rodriguez- Alvarez2, Douglas R. Lazzaro4 and Isabel M. McFarlane*,2

1Department of Medicine, Division of Rheumatology SUNY Upstate Medical University, Syracuse, NY 13210, USA
2Department of Medicine, Division of Rheumatology SUNY, Downstate Health Sciences University/Health + Hospitals Kings County Brooklyn, NY 11203, USA
3Department of Ophthalmology SUNY, Downstate Health Sciences University/Health + Hospitals Kings County Brooklyn, NY 11203, USA
4Department of Ophthalmology NYU Langone Health Eye Center Brooklyn, NY 11209, USA
Dr. Isabel M. McFarlane, Department of Internal Medicine, Division of Rheumatology, SUNY Downstate Health Sciences University, Brooklyn, NY 11203, USA, Tel: 718-270-2930, Fax: 718-270-1324; E-mail: Isabel.McFarlane@downstate.edu
13 September 2019; 07 November 2019; 09 November 2019
Bhamra MS, Gondal I, Amarnani A, Betesh S, Zhyvotovska A, et al. (2019) Ocular Manifestations of Rheumatoid Arthritis: Implications of Recent Clinical Trials. Int J Clin Res Trials 4: 139. doi: https://doi.org/10.15344/2456-8007/2019/139
This work is supported in part by Dr. Moro O. Salifu’s efforts through NIH Grant # S21MD012474.

Abstract

While rheumatoid arthritis (RA) typically presents with synovitis of the small and medium joints of the hands, ocular manifestations of the disease are generally overlooked and largely underdiagnosed.
These complications usually present in longstanding RA population and occasionally represents the first manifestation of the disease and generally affect the anterior chamber of the eye, leading to keratoconjunctivitis sicca, episcleritis, scleritis, peripheral ulcerative keratitis and anterior uveitis.
In this review, we present the current understanding of the pathophysiologic mechanisms for ocular disease in RA, including the role of oxidative stress, cytokine imbalance, chronic inflammation, vascular permeability, immune complex deposition and the role of T-cells as well as the contribution of tear hyperosmolarity among other factors.
We also discuss the clinical presentation and diagnosis of each of the ocular disease entities highlighting the latest strategies in the management of this serious disorders that could potentially lead to blindness and the implications of recently completed and ongoing clinical trials in the field. While RA disease control is the cornerstone in the management of RA-associated ocular manifestations, early recognition of ocular pathology with prompt referral to ophthalmology is of paramount importance in order to prevent blindness and improve the quality of life in this patient population.